Antiandrogen

DRUG4 trials

Sponsors

Alliance for Clinical Trials in Oncology, University of Washington, Göteborg University, UNC Lineberger Comprehensive Cancer Center

Conditions

Breast CancerEstrogen-receptor-positive Breast CancerHormone Receptor Negative Breast CarcinomaMetastatic Breast CancerProstate CancerProstatic NeoplasmsTriple Negative Breast Cancer

Phase 2

Androgen Suppression Plus Radiation Therapy in Treating Patients With Prostate Cancer

CompletedNCT00006359

Alliance for Clinical Trials in OncologyProstate Cancer

Start: 2000-09-30End: 2012-03-31Updated: 2016-07-18

Exisulind and Intermittent Androgen Suppression (ADT) in Biochemical Relapsed Prostate Cancer

CompletedNCT00283803

University of WashingtonProstate Cancer

Start: 2002-03-12End: 2011-10-31Updated: 2018-08-07

Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies

RecruitingNCT07340541

UNC Lineberger Comprehensive Cancer CenterBreast Cancer, Estrogen-receptor-positive Breast Cancer, Hormone Receptor Negative Breast Carcinoma +2

Start: 2026-02-16End: 2031-06-02Target: 700Updated: 2026-09-18

Phase 3

Early Rising PSA Endocrine Treatment Versus Chemo-endocrine Therapy- SPCG14

Göteborg UniversityProstatic Neoplasms

Start: 2009-02-28End: 2023-04-30Updated: 2021-08-18